Acutus Medical (AFIB)
(Delayed Data from OTC)
$0.03 USD
-0.01 (-21.28%)
Updated Aug 5, 2024 03:10 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Acutus Medical, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 7 | 16 | 17 | 8 | 3 |
Cost Of Goods | 10 | 32 | 33 | 16 | 9 |
Gross Profit | -3 | -16 | -16 | -7 | -6 |
Selling & Adminstrative & Depr. & Amort Expenses | 9 | 12 | 96 | 84 | 66 |
Income After Depreciation & Amortization | -12 | -27 | -112 | -91 | -73 |
Non-Operating Income | 6 | -7 | 0 | -5 | -2 |
Interest Expense | 6 | 5 | 6 | 6 | 22 |
Pretax Income | -12 | -40 | -118 | -102 | -97 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -12 | -40 | -118 | -102 | -97 |
Extras & Discontinued Operations | -70 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -82 | -40 | -118 | -102 | -97 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -12 | -7 | -103 | -86 | -52 |
Depreciation & Amortization (Cash Flow) | 0 | 20 | 10 | 5 | 21 |
Income After Depreciation & Amortization | -12 | -27 | -112 | -91 | -73 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 29.10 | 28.32 | 28.65 | 11.41 | NA |
Diluted EPS Before Non-Recurring Items | -0.41 | -1.40 | -4.22 | -4.97 | NA |
Diluted Net EPS (GAAP) | -2.81 | -1.40 | -4.11 | -8.94 | -144.41 |
Fiscal Year end for Acutus Medical, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 3.63 | -7.53 | 5.24 | 5.29 |
Cost Of Goods | NA | 3.66 | -13.15 | 8.60 | 8.06 |
Gross Profit | NA | -0.03 | 5.61 | -3.36 | -2.77 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.54 | -29.60 | 9.58 | 14.40 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -0.57 | 35.21 | -12.94 | -17.17 |
Non-Operating Income | NA | 0.00 | 1.82 | 1.18 | 0.22 |
Interest Expense | NA | 1.48 | 1.54 | 1.41 | 1.40 |
Pretax Income | NA | -2.06 | 35.97 | -13.16 | -18.35 |
Income Taxes | NA | 0.00 | -0.01 | 0.08 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -2.06 | 35.98 | -13.24 | -18.35 |
Extras & Discontinued Operations | NA | 0.44 | -69.74 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -1.62 | -33.77 | -13.24 | -18.35 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 29.69 | NA | 29.26 | 29.04 |
Diluted EPS Before Non-Recurring Items | NA | -0.07 | NA | -0.45 | -0.63 |
Diluted Net EPS (GAAP) | NA | -0.06 | -1.16 | -0.45 | -0.63 |